These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36140361)

  • 1. The End of "One Size Fits All" Sepsis Therapies: Toward an Individualized Approach.
    Vincent JL; van der Poll T; Marshall JC
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the host response in sepsis: current approaches and future evidence.
    Bode C; Weis S; Sauer A; Wendel-Garcia P; David S
    Crit Care; 2023 Dec; 27(1):478. PubMed ID: 38057824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging and Personalized Intervention for Infection and Sepsis.
    Beckmann N; Salyer CE; Crisologo PA; Nomellini V; Caldwell CC
    Surg Infect (Larchmt); 2020 Nov; 21(9):732-744. PubMed ID: 32240042
    [No Abstract]   [Full Text] [Related]  

  • 6. Sepsis heterogeneity.
    Wang W; Liu CF
    World J Pediatr; 2023 Oct; 19(10):919-927. PubMed ID: 36735197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepsis-Pathophysiology and Therapeutic Concepts.
    Jarczak D; Kluge S; Nierhaus A
    Front Med (Lausanne); 2021; 8():628302. PubMed ID: 34055825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling pathways and intervention therapies in sepsis.
    Zhang YY; Ning BT
    Signal Transduct Target Ther; 2021 Nov; 6(1):407. PubMed ID: 34824200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach.
    Mokhtari B; Yavari R; Badalzadeh R; Mahmoodpoor A
    Can J Infect Dis Med Microbiol; 2022; 2022():3277274. PubMed ID: 35706715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepsis and infection: Two words that should not be confused.
    Vincent JL
    Front Med (Lausanne); 2023; 10():1156732. PubMed ID: 36968843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis endotypes identified by host gene expression across global cohorts.
    Chenoweth JG; Brandsma J; Striegel DA; Genzor P; Chiyka E; Blair PW; Krishnan S; Dogbe E; Boakye I; Fogel GB; Tsalik EL; Woods CW; Owusu-Ofori A; Oppong C; Oduro G; Vantha T; Letizia AG; Beckett CG; Schully KL; Clark DV
    Commun Med (Lond); 2024 Jun; 4(1):120. PubMed ID: 38890515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis target validation for repurposing and combining complement and immune checkpoint inhibition therapeutics.
    Rodrigues PRS; Picco N; Morgan BP; Ghazal P
    Expert Opin Drug Discov; 2021 May; 16(5):537-551. PubMed ID: 33206027
    [No Abstract]   [Full Text] [Related]  

  • 13. The beginning of personalized medicine in sepsis: small steps to a bright future.
    Christaki E; Giamarellos-Bourboulis EJ
    Clin Genet; 2014 Jul; 86(1):56-61. PubMed ID: 24579691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.
    Hattori Y; Hattori K; Suzuki T; Matsuda N
    Pharmacol Ther; 2017 Sep; 177():56-66. PubMed ID: 28232275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cells in Sepsis and Associated Organ Dysfunction: A Promising Future or Blind Alley?
    Horák J; Nalos L; Martínková V; Beneš J; Štengl M; Matějovič M
    Stem Cells Int; 2017; 2017():7304121. PubMed ID: 29098010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular basis of organ failure in sepsis-signaling during damage and repair processes.
    Bauer M; Wetzker R
    Med Klin Intensivmed Notfmed; 2020 May; 115(Suppl 1):4-9. PubMed ID: 32236799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of ALDH2 in Sepsis and the To-Be-Discovered Mechanisms.
    Pang J; Zheng Y; Han Q; Zhang Y; Sun R; Wang J; Xu F; Zhang Y; Ren J; Chen Y
    Adv Exp Med Biol; 2019; 1193():175-194. PubMed ID: 31368104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction: a therapeutic target in bacterial sepsis?
    Vincent JL; Ince C; Pickkers P
    Expert Opin Ther Targets; 2021 Sep; 25(9):733-748. PubMed ID: 34602020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunology of sepsis.
    van der Poll T; Shankar-Hari M; Wiersinga WJ
    Immunity; 2021 Nov; 54(11):2450-2464. PubMed ID: 34758337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.